DXCM
Dexcom
$76.65
▼ -1.71%
−$1.33
NASDAQ · Healthcare · Medical Devices
Dexcom
DXCM · NASDAQ · Healthcare · Medical Devices
$76.65
▼ -1.71% · −$1.33 today
fundamentals77.1 /100 vs peers · 100% coverage
strong
5 of 5 metrics · 100% coverage
Revenue growth (TTM)16.1
15% above Sector 5Y avg avg · favorableSector 5Y avg: 14.1
EPS growth (TTM)76.2
563% above Sector 5Y avg avg · favorableSector 5Y avg: 11.5
EPS forecast (5Y)20.9
44% above Sector fwd avg avg · favorableSector fwd avg: 14.5
EPS next year19.3
strong pace
EPS growth (Q/Q)92.2
strong pace
Missing inputs are treated as neutral uncertainty; compared with sector peers where available.
vs sector peers
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| DXCMDexcom | $29.58B | 32.9 | +16.1% | 77 |
| GMEDGlobus Medical | $10.60B | 18.2 | +23.5% | 78 |
| INDVIndivior | $4.94B | 20.5 | +10.3% | 78 |
| LLYEli Lilly and Company | $1.12T | 42.8 | +47.4% | 76 |
| BSXBoston Scientific Corporation | $66.54B | 18.8 | +17.4% | 73 |
